The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pepia John C since 2017.
This trader's CIK number is 1674717.
At the time of last reporting, Pepia John C was the Principal Accounting Officer of Mednax, Inc.. (stock ticker symbol MD).
Also see all insider trading activities at Mednax, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | MD | 0 | $0 | 24,238 | $708,775 | 0 | $0 |
2020 | MD | 0 | $0 | 0 | $0 | 7,862 | $0 |
2019 | MD | 0 | $0 | 2,500 | $91,500 | 0 | $0 |
2018 | MD | 0 | $0 | 16,016 | $786,363 | 6,000 | $166,290 |
2017 | MD | 0 | $0 | 8,500 | $457,242 | 8,500 | $237,652 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-11-10 | MD | Sale | 5,000 | 28.45 | 142,250 |
2021-10-29 | MD | Sale | 9,238 | 26.87 | 248,225 |
2021-09-02 | MD | Sale | 10,000 | 31.83 | 318,300 |
2020-03-01 | MD | Option Ex | 7,862 | .00 | 0 |
2019-01-22 | MD | Sale | 2,500 | 36.60 | 91,500 |
2018-08-14 | MD | Sale | 3,500 | 48.18 | 168,640 |
2018-06-12 | MD | Sale | 6,516 | 46.56 | 303,371 |
2018-05-22 | MD | Option Ex | 3,000 | 27.71 | 83,145 |
2018-05-22 | MD | Sale | 3,000 | 46.43 | 139,290 |
2018-03-13 | MD | Option Ex | 3,000 | 27.71 | 83,145 |
2018-03-13 | MD | Sale | 3,000 | 58.35 | 175,062 |
2017-12-12 | MD | Option Ex | 3,000 | 27.71 | 83,145 |
2017-12-12 | MD | Sale | 3,000 | 51.58 | 154,740 |
2017-09-12 | MD | Option Ex | 3,000 | 27.71 | 83,145 |
2017-09-12 | MD | Sale | 3,000 | 42.85 | 128,550 |
2017-02-16 | MD | Option Ex | 2,500 | 28.55 | 71,362 |
2017-02-16 | MD | Sale | 2,500 | 69.58 | 173,952 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pepia John C (Principal Accounting Officer of Mednax, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.